Maynard Um
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) Misses Q1 EPS by 9c
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) Reiterated at Market Outperform by Citizens Amid Litigation
-
-
-
-
-
-
-
RBC Capital on Ocular Therapeutix (OCUL): Weakness a Buying Opportunity
-
-
-
-
-
-
-
Ocular (OCUL) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c
-
-
-
-
-
-
-
Ocular Therapeutix (OCUL) files mixed shelf
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Ocular Therapeutix (OCUL)
-
433,615 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

